UNSPSC 51421700: Corticosteroid corticotropin-releasing hormones

Corticosteroids made from a peptide of about 41 amino acids that stimulates the release of adrenocorticotropic hormone. crh is synthesized by neurons in the paraventricular nucleus of the hypothalamus.

UNSPSC 51421700 Corticosteroid corticotropin-releasing hormones is a Class code that bears little relationship to the state and local procurement activity recently tagged under it. The code's nominal scope — pharmaceutical hormones — does not align with the actual work being solicited. Recent state and local opportunities under this code show no purchasing of corticosteroids or corticotropin-releasing hormones; instead, Seminole County, Florida has posted an IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission has issued a Request for Information on direct-to-manufacturer prescription programs. Neither solicitation involves hormone products. The code shows minimal relevant recent activity and appears to reflect a mislabeling in the state and local procurement database rather than an active, coherent category.

The two posted opportunities span different issuing bodies and procurement phases. Seminole County's IFB 60459723LAS, due July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida — a public health commodities purchase unrelated to the code's hormone focus. Texas HHS's RFI HHS0017013, posted April 3, 2026, is a preliminary market-intelligence gathering effort on direct pharmacy contracting models, also disconnected from corticosteroid procurement. The mismatch between the code's stated scope and the actual solicitations suggests this code is not reliably used in current state and local procurement workflows for pharmaceutical purchasing and should not be pursued on the assumption that recent activity reflects genuine demand for hormone products.